NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility,and auto-immune diseases . Our unique capabilities provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough therapies.Daniel Teper is a serial entrepreneur and a corporate strategist who has founded, led, and advised several biopharma companies both in the US and internationally. Daniel has a proven ability to identify and execute strategic partnerships, mergers and acquisitions, and financing deals that create value for all stakeholders. Daniel holds a PharmD degree from Université Paris-Saclay, an MBA from INSEAD, and completed executive programs at Wharton and MIT.